SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-072855
Filing Date
2024-06-18
Accepted
2024-06-18 16:49:07
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 tm2417469-1_s3.htm S-3 446616
2 EXHIBIT 5.1 tm2417469d2_ex5-1.htm EX-5.1 8338
3 EXHIBIT 23.1 tm2417469d2_ex23-1.htm EX-23.1 2623
4 EX-FILING FEES tm2417469d2_ex-filingfees.htm EX-FILING FEES 12563
5 GRAPHIC lg_centurythera-4c.jpg GRAPHIC 19514
  Complete submission text file 0001104659-24-072855.txt   498211
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280310 | Film No.: 241052581
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)